Sign inJoin waitlistJoin the waitlist

TO

Thomas O’Dorisio

Credentials: · ·

History

Endocrinology, Diabetes, and Metabolism
1974–1976
Internal Medicine
1971–1974
Creighton University School of Medicine
1967–1971

Research

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
New England Journal of Medicine · 2017 · 2,601 citations
The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 576 citations
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial
Journal of Clinical Oncology · 2010 · 492 citations

SO
Sue O’Dorisio
61 papers
SC
Samuel Cataland
52 papers
James Howe
45 papers
EW
Eugene Woltering
36 papers
Andrew Bellizzi
27 papers
Yusuf Menda
22 papers
Joseph Dillon
20 papers
KO
Kwame Osei
20 papers
HM
Hagop Mekhjian
19 papers
CE
Christopher Ellison
18 papers
KS
Kenneth Sirinek
18 papers · 1 as a resident
EM
Ernest Mazzaferri
16 papers

Grants

Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
National Cancer Institute · P50
Project lead · $1.4M · University of Iowa
2015–2022
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $56.4K · University of Iowa
2004–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · Ohio State University